Search

Insecticide resistance in the common bed bug, C imex lectularius Linnaeus has been suspected in Australia with anecdotal reports of poor product performance. To investigate this possibility, LD50 values were determined via topical application of technical grade permethrin, deltamethrin, bendiocarb, pirimiphos-methyl and imidacloprid serially diluted in acetone to a suspected resistant field-collected strain and a susceptible laboratory strain. All compounds tested against the susceptible strain were efficacious. However, for the field strain, only pirimiphos-methyl and imidacloprid showed high levels of activity. Resistance was confirmed in the field-collected strain to the pyrethroids and bendiocarb, but not to pirimiphos-methyl or imidacloprid. Resistance factors ('resistant' LD50/susceptible LD50) for each compound were: permethrin ≈ 1.235 million, deltamethrin ≈ 370 000, bendiocarb ≈ 250, pirimiphos-methyl = 2.6, imidacloprid = 2.6. Bendiocarb, permethrin and deltamethrin all failed to return greater than 60% mortality at the maximum dose of 100 μg/μ L. This research has significant operational implications for bed bug control and the registration process of new products in Australia. [ABSTRACT FROM AUTHOR]

Large-scale extraction of the leaves of the Australian rainforest tree Maytenus bilocularis followed by extensive purification studies afforded the targeted and abundant dihydro-β-agarofuran, bilocularin A, in sufficient quantities (>500 mg) for detailed semi-synthetic chemistry. Eight bilocularin A carbamate analogues were synthesised using a series of commercially available isocyanate reagents in high purity (>95%) and variable yields (9-91%). All previously undescribed analogues were spectroscopically characterised using NMR, UV, IR and MS data. One compound afforded crystalline material and subsequent single crystal X-ray analysis (Cu-Kα) confirmed the chemical structure along with the absolute configuration. All compounds were evaluated for anti-proliferative activity against the human prostate cancer cell line LNCaP; none of the compounds showed significant (>50%) growth inhibition at 20 μM. Compounds were also tested for their ability to inhibit leucine transport in LNCaP cells, and two analogues showed moderate activity with IC 50 values of 8.9 and 8.5 μM. This is the first reported synthesis of dihydro-β-agarofuran carbamate derivatives., (Copyright © 2020 Elsevier Ltd. All rights reserved.)